Read all posts

CardioBreak: LDL Targets, Fish Oil ‘Truthiness’

For the PCSK9 inhibitors, "reasonable utilization management can occur only with a return to reliance on lipid goals," pharmacy giant CVS argued in urging the American College of Cardiology/American Heart Association to rethink their prevention guidelines. More on off-label marketing expansion: a U.S.

Read the article on Medpagetoday

Dr. Sears Comments:

Dr. Barry Sears

The reason that Amarin is fighting for off-label marketing is because sales of its product for its approved application are pathetic.


Leave a Reply

Your email address will not be published. Required fields are marked *